home / stock / auph / auph news


AUPH News and Press, Aurinia Pharmaceuticals Inc From 12/09/21

Stock Information

Company Name: Aurinia Pharmaceuticals Inc
Stock Symbol: AUPH
Market: NASDAQ
Website: auriniapharma.com

Menu

AUPH AUPH Quote AUPH Short AUPH News AUPH Articles AUPH Message Board
Get AUPH Alerts

News, Short Squeeze, Breakout and More Instantly...

AUPH - Aurinia gains 7% on positive Lupkynis data in lupus nephritis study

Aurinia Pharmaceuticals (NASDAQ:AUPH) perks up 6.8% premarket after announcing positive topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of Lupkynis (voclosporin) for the treatment of adults with active lupus nephritis (LN), a ser...

AUPH - Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS(TM) (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)

- Study demonstrated a favorable risk/benefit profile over a three-year period, with safety comparable to AURORA 1, and sustained efficacy - - Topline results show sustained meaningful reductions in proteinuria compared to mycophenolate mofetil (MMF) and low-dose oral corticosteroid...

AUPH - Bristol is one of the worst performing biopharmas this year. Will 2022 be different?

On Tuesday, Bristol-Myers Squibb (NYSE:BMY) reached a 52-week low of $53.22. Unlike most of its large U.S. pharmaceutical company peers which are doing well in 2021, its shares are down 9.2% for the year. While Bristol's Q3 2021 revenue and profit beat Street expectations in October...

AUPH - Hot Stocks: Retail stocks rise; TOL hits high; NRDS sets post-IPO low; AUPH takeover rumor; KIRK plunges

Wall Street's volatile week continued on Thursday, with stocks bouncing back after their recent losses. The rebound included a strong performance from a collection of retail names, as investors found hope in a handful of earnings reports that higher costs wouldn't necessarily obliterate margi...

AUPH - Why Aurinia Pharmaceuticals Stock Bolted Higher Today

Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are up by a noteworthy 15.5% as of 1:10 p.m. ET Thursday afternoon. The drugmaker's stock is perking up today in response to renewed buyout speculation. Rumors began to swirl about a possible buyo...

AUPH - EXPR Stock: 7 Reasons Why Express Investors Are Feeling Giddy Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors in Express (NYSE: EXPR ) stock are celebrating on Thursday thanks to the release of the company’s Q3 2021 earnings report. Source: Helen89 / Shutterstock.com Let’s break down that earni...

AUPH - NLSP, DAWN and MDJH among Mid-day movers

Gainers: Biofrontera (NASDAQ:BFRI) +36%. CF Acquisition (NASDAQ:CFVIU) +19%. Day One (NASDAQ:DAWN) +16%. Terns Pharmaceuticals (NASDAQ:TERN) +15%. Duluth Holdings (NASDAQ:DLTH) +15%. Snowflake (NYSE:SNOW) +14%. Aurinia Pharmaceuticals (NASDAQ:AUPH) +14%. Express (NYSE:EXPR) +13%. Vor Biopharm...

AUPH - BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biofrontera (NASDAQ: BFRI ) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office (USPTO). Source: Bukhta Yurii / Shutterstock.com According to a news rele...

AUPH - AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurinia Pharma (NASDAQ: AUPH ) stock is on the rise Thursday as investors hold out hope for a takeover of the company. Source: Shutterstock.com The most recent reports claim that Novartis (NYSE: NVS ) co...

AUPH - Moderna, BioNTech among weekly healthcare gainers amid fears over new COVID-19 variant

A newly detected coronavirus variant in Africa created panic and sparked a market selloff in the holiday-shortened week. However, the developers of COVID-19 vaccines and therapeutics advanced while several common stock offerings pressured decliners. Despite the outperformance of biotech stock...

Previous 10 Next 10